Literature DB >> 32772230

LncRNA DDX11-AS1: a novel oncogene in human cancer.

Yubin Feng1,2, Maomao Wu3, Shuang Hu1,2, Xiaoqing Peng4,5, Feihu Chen6,7.   

Abstract

Long noncoding RNA (lncRNA) is a newly identified type of noncoding RNA with a length of more than 200 nucleotides. The latest research shows that lncRNAs play important roles in the occurrence and development of human tumours by acting both as carcinogenic genes and as tumour suppressor genes. LncRNAs plays a role in various biological processes, such as cell growth, apoptosis, migration and invasion. The newly discovered lncRNA DDX11-AS1 is abnormally highly expressed in various malignant tumours, such as hepatocellular carcinoma, colorectal cancer, osteosarcoma, bladder cancer, NSCLC and gastric cancer. DDX11-AS1 mainly regulates the expression of related genes through direct or indirect ways to perform its functions in carcinogenicity. These results indicate that DDX11-AS1 may be a marker or therapeutic target of tumours. This review summarizes the biological function and mechanism of DDX11-AS1 in the process of tumour development.

Entities:  

Keywords:  Diagnosis; Prognosis; Therapeutic target; lncRNA DDX11-ASA

Mesh:

Substances:

Year:  2020        PMID: 32772230     DOI: 10.1007/s13577-020-00409-8

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  67 in total

Review 1.  Prognostic and clinicopathological value of long noncoding RNA XIST in cancer.

Authors:  Jianwei Zhu; Fanyang Kong; Ling Xing; Zhendong Jin; Zhaoshen Li
Journal:  Clin Chim Acta       Date:  2018-01-05       Impact factor: 3.786

Review 2.  Epigenetic regulation by long noncoding RNAs.

Authors:  Jeannie T Lee
Journal:  Science       Date:  2012-12-14       Impact factor: 47.728

Review 3.  Noncoding RNA: Current Deep Sequencing Data Analysis Approaches and Challenges.

Authors:  Dario Veneziano; Sebastiano Di Bella; Giovanni Nigita; Alessandro Laganà; Afredo Ferro; Carlo M Croce
Journal:  Hum Mutat       Date:  2016-09-05       Impact factor: 4.878

4.  Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.

Authors:  Shiyou Zhu; Wei Li; Jingze Liu; Chen-Hao Chen; Qi Liao; Ping Xu; Han Xu; Tengfei Xiao; Zhongzheng Cao; Jingyu Peng; Pengfei Yuan; Myles Brown; Xiaole Shirley Liu; Wensheng Wei
Journal:  Nat Biotechnol       Date:  2016-10-31       Impact factor: 54.908

5.  A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice.

Authors:  Ping Li; Xiangbo Ruan; Ling Yang; Kurtis Kiesewetter; Yi Zhao; Haitao Luo; Yong Chen; Marjan Gucek; Jun Zhu; Haiming Cao
Journal:  Cell Metab       Date:  2015-03-03       Impact factor: 27.287

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

7.  Targeting Human Long Noncoding Transcripts by Endoribonuclease-Prepared siRNAs.

Authors:  Mirko Theis; Maciej Paszkowski-Rogacz; Ina Weisswange; Debojyoti Chakraborty; Frank Buchholz
Journal:  J Biomol Screen       Date:  2015-04-24

8.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

9.  The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.

Authors:  Peng Han; Jing-Wen Li; Bo-Miao Zhang; Jia-Chen Lv; Yong-Min Li; Xin-Yue Gu; Zhi-Wei Yu; Yun-He Jia; Xue-Feng Bai; Li Li; Yan-Long Liu; Bin-Bin Cui
Journal:  Mol Cancer       Date:  2017-01-13       Impact factor: 27.401

10.  Landscape of transcription in human cells.

Authors:  Sarah Djebali; Carrie A Davis; Angelika Merkel; Alex Dobin; Timo Lassmann; Ali Mortazavi; Andrea Tanzer; Julien Lagarde; Wei Lin; Felix Schlesinger; Chenghai Xue; Georgi K Marinov; Jainab Khatun; Brian A Williams; Chris Zaleski; Joel Rozowsky; Maik Röder; Felix Kokocinski; Rehab F Abdelhamid; Tyler Alioto; Igor Antoshechkin; Michael T Baer; Nadav S Bar; Philippe Batut; Kimberly Bell; Ian Bell; Sudipto Chakrabortty; Xian Chen; Jacqueline Chrast; Joao Curado; Thomas Derrien; Jorg Drenkow; Erica Dumais; Jacqueline Dumais; Radha Duttagupta; Emilie Falconnet; Meagan Fastuca; Kata Fejes-Toth; Pedro Ferreira; Sylvain Foissac; Melissa J Fullwood; Hui Gao; David Gonzalez; Assaf Gordon; Harsha Gunawardena; Cedric Howald; Sonali Jha; Rory Johnson; Philipp Kapranov; Brandon King; Colin Kingswood; Oscar J Luo; Eddie Park; Kimberly Persaud; Jonathan B Preall; Paolo Ribeca; Brian Risk; Daniel Robyr; Michael Sammeth; Lorian Schaffer; Lei-Hoon See; Atif Shahab; Jorgen Skancke; Ana Maria Suzuki; Hazuki Takahashi; Hagen Tilgner; Diane Trout; Nathalie Walters; Huaien Wang; John Wrobel; Yanbao Yu; Xiaoan Ruan; Yoshihide Hayashizaki; Jennifer Harrow; Mark Gerstein; Tim Hubbard; Alexandre Reymond; Stylianos E Antonarakis; Gregory Hannon; Morgan C Giddings; Yijun Ruan; Barbara Wold; Piero Carninci; Roderic Guigó; Thomas R Gingeras
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

View more
  12 in total

1.  Long non-coding RNA DDX11-AS1 promotes the proliferation and migration of glioma cells by combining with HNRNPC.

Authors:  Zijin Xiang; Qiaoli Lv; Yujun Zhang; Xueru Chen; Ren Guo; Shikun Liu; Xiangdong Peng
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-26       Impact factor: 10.183

2.  Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.

Authors:  Haiting Zhou; Yi He; Lingling Li; Cheng Wu; Guoqing Hu
Journal:  Int J Med Sci       Date:  2021-01-19       Impact factor: 3.738

3.  LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p.

Authors:  Hong Zeng; Yongqiang Wei; Xiaolei Wei; Ru Feng
Journal:  Cancer Manag Res       Date:  2021-04-30       Impact factor: 3.989

Review 4.  Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs.

Authors:  Tristan Cardon; Isabelle Fournier; Michel Salzet
Journal:  Front Cell Dev Biol       Date:  2021-12-23

Review 5.  Clinicopathological and prognostic significance of long non-coding RNA EWSAT1 in human cancers: A review and meta analysis.

Authors:  Jian Wen; Haima Li; Dongdong Li; Xieping Dong
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

6.  Knockdown of lncRNA AL928768.3 inhibits multiple myeloma cell proliferation by inducing cell cycle arrest in G0/G1 phase.

Authors:  Qian Shen; Qi Jiang; Zhirong Cong; Yin Zhou; Xiaoxiao Huang; Li Zhu; Xiaohong Xu; Juan Qian
Journal:  Ann Transl Med       Date:  2022-02

7.  FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta-Analysis and Bioinformatics Analysis.

Authors:  Guangming Zhang; Yongfeng Wang; Xiaoyong Han; Tingting Lu; Liangyin Fu; Haojie Jin; Kehu Yang; Hui Cai
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 8.  The Role of lncRNA PCAT6 in Cancers.

Authors:  Siying Wang; Zhenyao Chen; Jingyao Gu; Xin Chen; Zhaoxia Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

Review 9.  The Genome Stability Maintenance DNA Helicase DDX11 and Its Role in Cancer.

Authors:  Mohammad Mahtab; Ana Boavida; Diana Santos; Francesca M Pisani
Journal:  Genes (Basel)       Date:  2021-03-10       Impact factor: 4.096

10.  lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells.

Authors:  Zhiping Liu; Kaibing Hu; Xiang Wang; Youqian Zhang; Weiping Wang; Yindi Wu
Journal:  Open Med (Wars)       Date:  2022-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.